The following
joint Editorial was also published in the Journal of the American
Chemical Society (DOI: 10.1021/jacs.0c06482).The chronic effects of
institutionalized
racism in America have been laid bare in recent weeks by murders caught
on film as well as by the disproportionate impact of COVID-19 on Black
and LatinX people. Against this backdrop, last week Angewandte Chemie published (and then removed) an article entitled, “‘Organic
synthesis—Where now?’ is 30 years old. A reflection
on the current state of affairs”. It has been heartening
to see the near unanimity of the chemistry community in condemning
the archaic views about diversity, inclusion, and mentoring as well
as the xenophobia expressed in this paper. This condemnation included
a statement by Angewandte that “the values
expressed in this piece do not reflect our values of fairness, trustworthiness,
and social awareness”, denunciations from chemical societies
around the world, the resignation of a large portion of the journal’s
international advisory board, and an outpouring of criticism on social
media.However, from my perspective it is hard not to feel that
some of
the same people who are loudly condemning this piece are (at best)
not doing enough to combat these systemic problems and (at worst)
actively contributing to them. I encourage everyone in the field who
has disavowed the views expressed in this article to ask themselves
what they are actively doing to address them. Understand that
nearlyof
your colleagues who is also a member of an underrepresented group
(women, BIPOC) has been told at some point in their career that they
only received a position, fellowship, award, or invitation because
of their minority status. Maybe you have even said or thought
something like this yourself. Or heard someone else say it without
speaking up.At this stage, words and condemnation are not enough.
Actions are
needed. If you recognize that a more diverse workforce enhances the
field of chemistry, here are some examples of things that you can
actually do:Actively promote and advocate for women
and underrepresented minority students, faculty, and co-workers. Consider
this a priority in the same way that you consider it a priority
to advocate for yourself and your close friends. For example:Attend their talks and posters at scientific
meetings and actively engage with their science. Talk to them about
their scientific work, ask questions, and discuss their results.Let them know if you liked their recent
paper or presentation.
An enthusiastic e-mail or phone call can have a tremendous impact
at all career stages.Nominate their
work for coverage in press (e.g., for
journal highlights, C&E News, Chemistry
World, etc.). Women and researchers from underrepresented
minority groups are frequently overlooked in press coverage of scientific
work. If you see a great talk or read a great paper, let the press
know in the same way that you would for your own work.Nominate them for awards. Do not just
assume that they
have already been nominated by someone else. Even if they have, your
endorsement and support is still meaningful.Amplify their voices. When they make a point or ask
an insightful question in a meeting, explicitly give them credit and
repeat their message.Lead by example. If you truly value
diversity, work even harder to make sure that your team reflects your
values. If you are a faculty member, use seminar visits and conferences
to meet and actively recruit talented and diverse scientists to your
group and as future faculty colleagues. Follow up and encourage the
people that you meet to join your team or department. Proactively
advocate within your department for hiring a diverse cohort of graduate
students and faculty recruits.Hiring a diverse team/set of colleagues is not enough. Active support and mentoring
are crucial for the success of all scientists! Too often, I have heard
other professors say that formal mentoring is a waste of time and
that truly talented scientists will be successful without it. Scientists
from majority groups take for granted the extensive mentorship that
they receive from their colleagues just by being “part of the
club”. Formal, informal, and meaningful mentoring for
everyone is crucial for leveling the playing field and maximizing
the success of all of the scientists in your group and department
as well as in the chemistry community at large.Speak up when you see or hear discriminatory
words/actions or when you hear implicit biases coming into a discussion.
Do not rely on members of underrepresented groups to raise these concerns.
If they do, listen, support them, and amplify their voices.Educate yourself and your
co-workers
on the scientific literature that shows how systemic and insidious
bias is in science. Some valuable resources on both explicit and implicit
bias can be found here: https://advance.umich.edu/stride-readings/. Use these data to refute claims that science is purely a meritocracy,
that the playing field is inherently equal for everyone, and that
scientists are being hired/promoted solely on their merits.For scientific editors
(including those
of us at ACS publications like the Journal of the American
Chemical Society and ACS Central Science): realize that you often play a critical role in propagating inequities
in science. Carefully consider your procedures and processes with the following
questions in mind:What papers are being triaged, reviewed, and accepted
in your journal? For example, what is the representation of women
and underrepresented minority authors and reviewers at each stage?
In many cases, these data will reveal that your journal and process
is not as objective and unbiased as you think. Be transparent about
these data and consider ways to fix any inequities that are revealed.Who is appealing your editorial decisions,
and how are
you deciding whether to reconsider their manuscripts? In my own Associate
Editor office at JACS, senior white male authors
are among the most aggressive in appealing negative decisions. This
has the potential to play a significant role in whose papers ultimately
receive reconsideration and/or appear in a journal.What articles are you recommending for press coverage?
How do you choose which articles to highlight? Are specific authors
(or demographics) disproportionately represented in press coverage
from your journal?This list is meant to provide a starting point for all of us as
we work to support and promote the careers of diverse members of our
community. I know that there are many other good ideas, and I welcome
an open and continuing discussion of these moving forward. Again, actionsnot just words are required to tackle
systemic inequities, and we all can and should be doing more. Now
is the time to channel this Global outrage to ensure that the chemical
sciences benefit from the contributions, talents, and creativity of
all humans.
Authors: Cynthia J Burrows; Jiaxing Huang; Shu Wang; Hyun Jae Kim; Gerald J Meyer; Kirk Schanze; T Randall Lee; Jodie L Lutkenhaus; David Kaplan; Christopher Jones; Carolyn Bertozzi; Laura Kiessling; Mary Beth Mulcahy; Craig W Lindsley; M G Finn; Joel D Blum; Prashant Kamat; Wonyong Choi; Shane Snyder; Courtney C Aldrich; Stuart Rowan; Bin Liu; Dennis Liotta; Paul S Weiss; Deqing Zhang; Krishna N Ganesh; Harry A Atwater; J Justin Gooding; David T Allen; Christopher A Voigt; Jonathan Sweedler; Alanna Schepartz; Vincent Rotello; Sébastien Lecommandoux; Shana J Sturla; Sharon Hammes-Schiffer; Jillian Buriak; Jonathan W Steed; Hongwei Wu; Julie Zimmerman; Bryan Brooks; Phillip Savage; William Tolman; Thomas F Hofmann; Joan F Brennecke; Thomas A Holme; Kenneth M Merz; Gustavo Scuseria; William Jorgensen; Gunda I Georg; Shaomeng Wang; Philip Proteau; John R Yates; Peter Stang; Gilbert C Walker; Marc Hillmyer; Lynne S Taylor; Teri W Odom; Erick Carreira; Kai Rossen; Paul Chirik; Scott J Miller; Joan-Emma Shea; Anne McCoy; Martin Zanni; Gregory Hartland; Gregory Scholes; Joseph A Loo; James Milne; Sarah B Tegen; Daniel T Kulp; Julia Laskin Journal: ACS Pharmacol Transl Sci Date: 2020-06-19